Kristin R. Wildsmith

Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates

Yang Yu, Jasvinder K. Atwal, Yin Zhang et al. · Science Translational Medicine · 2014 · 369 citations

Pharmacy, Neuroscience, Pharmacology +17

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

Edmond Teng, Paul T. Manser, Karen Pickthorn et al. · JAMA Neurology · 2022 · 191 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Claudia Cicognola, Gunnar Brinkmalm, Jessica Wahlgren et al. · Acta Neuropathologica · 2018 · 174 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

Daniel S. Spellman, Kristin R. Wildsmith, Lee Honigberg et al. · PROTEOMICS - CLINICAL APPLICATIONS · 2015 · 169 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE)

Stephen Salloway, Lee Honigberg, Michael E. Ward et al. · Alzheimer s Research & Therapy · 2018 · 152 citations · Full text

Medicine, Neurology, Pharmacology +17